Ni W - Search Results

1

Elimination of vitamin D receptor in vascular endothelial cells alters vascular function.

Ni W, Watts SW, Ng M, Chen S, Glenn DJ, Gardner DG. Ni W, et al. Hypertension. 2014 Dec;64(6):1290-8. doi: 10.1161/HYPERTENSIONAHA.114.03971. Epub 2014 Sep 8. Hypertension. 2014. PMID: 25201890 Free PMC article.

2

Arterial 5-hydroxytryptamine transporter function is impaired in deoxycorticosterone acetate and Nomega-nitro-L-arginine but not spontaneously hypertensive rats.

Ni W, Lookingland K, Watts SW. Ni W, et al. Hypertension. 2006 Jul;48(1):134-40. doi: 10.1161/01.HYP.0000225754.15146.dd. Epub 2006 Jun 5. Hypertension. 2006. PMID: 16754787

3

Tie-2Cre mediated deletion of the vitamin D receptor gene leads to improved skeletal muscle insulin sensitivity and glucose tolerance.

Ni W, Glenn DJ, Gardner DG. Ni W, et al. J Steroid Biochem Mol Biol. 2016 Nov;164:281-286. doi: 10.1016/j.jsbmb.2015.09.017. Epub 2015 Sep 11. J Steroid Biochem Mol Biol. 2016. PMID: 26369613 Free PMC article. Review.

4

Expression of the vitamin d receptor is increased in the hypertrophic heart.

Chen S, Glenn DJ, Ni W, Grigsby CL, Olsen K, Nishimoto M, Law CS, Gardner DG. Chen S, et al. Among authors: ni w. Hypertension. 2008 Dec;52(6):1106-12. doi: 10.1161/HYPERTENSIONAHA.108.119602. Epub 2008 Oct 20. Hypertension. 2008. PMID: 18936343 Free PMC article.

5

5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT).

Ni W, Watts SW. Ni W, et al. Clin Exp Pharmacol Physiol. 2006 Jul;33(7):575-83. doi: 10.1111/j.1440-1681.2006.04410.x. Clin Exp Pharmacol Physiol. 2006. PMID: 16789923 Review.

6

The 5-hydroxytryptamine2A receptor is involved in (+)-norfenfluramine-induced arterial contraction and blood pressure increase in deoxycorticosterone acetate-salt hypertension.

Ni W, Fink GD, Watts SW. Ni W, et al. J Pharmacol Exp Ther. 2007 May;321(2):485-91. doi: 10.1124/jpet.106.114017. Epub 2007 Feb 8. J Pharmacol Exp Ther. 2007. PMID: 17289838

7

Vascular reactivity, 5-HT uptake, and blood pressure in the serotonin transporter knockout rat.

Linder AE, Diaz J, Ni W, Szasz T, Burnett R, Watts SW. Linder AE, et al. Among authors: ni w. Am J Physiol Heart Circ Physiol. 2008 Apr;294(4):H1745-52. doi: 10.1152/ajpheart.91415.2007. Epub 2008 Feb 8. Am J Physiol Heart Circ Physiol. 2008. PMID: 18263707 Free article.

8

5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats.

Diaz J, Ni W, Thompson J, King A, Fink GD, Watts SW. Diaz J, et al. Among authors: ni w. J Pharmacol Exp Ther. 2008 Jun;325(3):1031-8. doi: 10.1124/jpet.108.136226. Epub 2008 Feb 27. J Pharmacol Exp Ther. 2008. PMID: 18305011

9

Lack of the serotonin transporter does not prevent mineralocorticoid hypertension in rat and mouse.

Ni W, Zhou H, Diaz J, Murphy DL, Haywood JR, Watts SW. Ni W, et al. Eur J Pharmacol. 2008 Jul 28;589(1-3):225-7. doi: 10.1016/j.ejphar.2008.06.012. Epub 2008 Jun 7. Eur J Pharmacol. 2008. PMID: 18573249 Free PMC article.

10

Cardiac steatosis potentiates angiotensin II effects in the heart.

Glenn DJ, Cardema MC, Ni W, Zhang Y, Yeghiazarians Y, Grapov D, Fiehn O, Gardner DG. Glenn DJ, et al. Among authors: ni w. Am J Physiol Heart Circ Physiol. 2015 Feb 15;308(4):H339-50. doi: 10.1152/ajpheart.00742.2014. Epub 2014 Dec 5. Am J Physiol Heart Circ Physiol. 2015. PMID: 25485904 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,022 results

Search Page

Filters